ArticleFrontiers in pharmacology2024

Exploring the pharmacokinetics and tolerability of cyclooxygenase inhibitor ampiroxicam: a phase I study on single and multiple oral doses.

Pengfei Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.